No results for ‘’
Coral Laboratories Ltd
₹585
(4.23%)
Sat, 19 Sept 2026, 02:47 pm
Health Technology
Pharmaceuticals: Other
24.5KCoral Laboratories Enterprise Value (EV)
| Particulars | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings ratio | 8.11 | 6.98 | 9.32 | 2.78 | 4.22 | 6.85 | 4.75 | 3.62 | 3.82 | 8.67 | 13.03 | 15.82 | 17.07 | 11.06 | 4.91 | 8.49 | 10.08 | 12.69 | 8.40 | 10.37 |
| Price to book ratio | 2.21 | 1.93 | 1.14 | 0.37 | 0.67 | 0.86 | 0.70 | 0.50 | 0.59 | 1.40 | 2.30 | 2.36 | 1.83 | 0.99 | 0.30 | 0.84 | 0.58 | 0.53 | 0.75 | 1.25 |
| Price to sales ratio | 1.71 | 1.29 | 0.79 | 0.27 | 0.58 | 0.88 | 0.68 | 0.54 | 0.61 | 1.43 | 2.20 | 2.70 | 2.30 | 1.24 | 0.50 | 1.19 | 1.21 | 1.05 | 1.59 | 2.18 |
| Price to cash flow ratio | 22.99 | 7.46 | 0 | 1.80 | 5.44 | 8.31 | 8.41 | 25.51 | 14.64 | 50.79 | 21.08 | 21.08 | 14.84 | 841.41 | 0 | 36.91 | 8.65 | 6 | 5.76 | 11.90 |
| Enterprise value | 35.13Cr | 46.1Cr | 35.21Cr | 15.05Cr | 22.02Cr | 27.52Cr | 22.95Cr | 17.42Cr | 23.48Cr | 77.73Cr | 153Cr | 248Cr | 203Cr | 91.45Cr | 10.7Cr | 86.33Cr | 37.82Cr | 17.34Cr | 45.54Cr | 147Cr |
| Enterprise value to EBITDA ratio | 6.95 | 6.46 | 7.11 | 2.87 | 3.36 | 4.81 | 3.30 | 2.72 | 2.62 | 7.11 | 11.81 | 10.61 | 13.22 | 7.30 | 1.75 | 5.27 | 4.45 | 4.29 | 2.76 | 5.46 |
| Debt to equity ratio | 0.09 | 0.36 | 0.43 | 0.23 | 0.10 | 0 | 0 | 0.01 | 0 | 0.02 | 0.01 | 0.02 | 0.01 | 0.01 | 0.05 | 0.05 | 0.04 | 0 | 0 | 0.02 |
| Return on equity % | 0 | 31.54 | 12.95 | 13.98 | 16.93 | 13.28 | 15.85 | 14.76 | 16.72 | 17.46 | 19.18 | 18.17 | 12.40 | 8.88 | 6.22 | 10.74 | 6.18 | 4.15 | 9.50 | 12.76 |
Coral Laboratories Ltd Enterprise Value
The Coral Laboratories Ltd Enterprise Value is a key financial metric used by investors to evaluate Coral Laboratories Ltd's valuation, profitability, and overall financial performance. Tracking the Coral Laboratories Ltd Enterprise Value helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.
Coral Laboratories Ltd (NSE: , BSE: 524506) is currently trading at ₹585, with a market capitalization of ₹209Cr. As a leading company in the Health technology sector and Pharmaceuticals: other industry, monitoring the Coral Laboratories Ltd Enterprise Value is essential for fundamental analysis.
Coral Laboratories Ltd Enterprise Value Current Value
The current Coral Laboratories Ltd Enterprise Value stands at 147Cr.
The latest Coral Laboratories Ltd Enterprise Value has increased compared to the previous period, indicating rising valuation or improved investor sentiment.
Coral Laboratories Ltd Enterprise Value Historical Trend
The Coral Laboratories Ltd Enterprise Value has shown the following historical trend:
- 2024: 147Cr
- 2023: 45.54Cr
- 2022: 17.34Cr
- 2021: 37.82Cr
- 2020: 86.33Cr
The recent rise in Coral Laboratories Ltd Enterprise Value suggests strengthening valuation trends and improving market sentiment.
What Coral Laboratories Ltd Enterprise Value Indicates for Investors
The Coral Laboratories Ltd Enterprise Value plays a crucial role in understanding the company's financial health and valuation.
This ratio is an important metric used in fundamental analysis of Coral Laboratories Ltd.
Coral Laboratories Ltd Enterprise Value Analysis Summary
The Coral Laboratories Ltd Enterprise Value remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Coral Laboratories Ltd Enterprise Value should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.
Regular tracking of Coral Laboratories Ltd Enterprise Value helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.